About the Company
We do not have any company description for Voyager Acquisition Corp./Cayman Islands at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Voyager Acquisition Corp./Cayman Islands
VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F ...
ZURICH, July 17, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (“VERAXA” or the "Company"), an emerging leader in designing novel cancer therapies, and Voyager Acquisition Corp., a Cayman Islands ...
VERAXA Biotech and Voyager Acquisition Corp. Announce Business ...
ZURICH, Switzerland, and BROOKLYN, New York, April 23, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (“VERAXA” or the “Company”), an emerging leader in designing novel cancer therapies, and ...
VERAXA Biotech to Attend Key Industry Conferences to ... - Morningstar
On April 22, 2025, VERAXA entered into a definitive business combination agreement (the "Business Combination Agreement") with Voyager Acquisition Corp., a Cayman Islands exempted company and ...
Voyager Acquisition Corp. Announces Pricing Of $220,000,000 Initial ...
Contacts Voyager Acquisition Corp. Mr. Adeel Rouf Chief Executive Officer, and Director 131 Concord Street Brooklyn, NY 11201 Email: ... MENAFN08082024004107003653ID1108534804 Legal Disclaimer: ...
VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F ...
ZURICH, July 17, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (“VERAXA” or the "Company"), an emerging leader in designing novel cancer therapies, and Voyager Acquisition Corp., a Cayman Islands ...
VERAXA Biotech and Voyager Acquisition Corp. Announce Business ...
ZURICH, SWITZERLAND, and BROOKLYN, NEW YORK, USA, April 23, 2025 -- VERAXA Biotech AG ("VERAXA” or the "Company”), an emerging leader in designing novel cancer therapies, and Voyager Acquisition Corp.
VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F ...
ZURICH, SWITZERLAND, July 17, 2025 -- VERAXA Biotech AG (“VERAXA” or the "Company"), an emerging leader in designing novel cancer therapies, and Voyager Acquisition Corp., a Cayman Islands exempted ...
VERAXA Biotech and Voyager Acquisition Corp. Announce Business ...
ZURICH, Switzerland, and BROOKLYN, New York, April 23, 2025 (GLOBE NEWSWIRE) -- VERAXA Biotech AG (“VERAXA” or the “Company”), an emerging leader in designing novel cancer therapies, and Voyager ...
VERAXA Biotech And Voyager Acquisition Corp. Announce Filing Of Form F ...
On April 22, 2025, VERAXA entered into a definitive business combination agreement (the "Business Combination Agreement") with Voyager Acquisition Corp., a Cayman Islands exempted company and ...
Similar Companies
Loading the latest forecasts...